In our clinical trial, we compared two different combinations of immunotherapy drugs to using a single immunotherapy drug, and found that either combination regimen doubled or tripled the response ...

Professor Yang and his team will develop next-generation microfluidics-based CTC detection technology, to further enhance the efficiency and sensitivity of cancer early screening and disease ...